BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Li W, Zhao Y, Kang, Fu W, Zheng X, Pang X, Du G. Members of FOX family could be drug targets of cancers. Pharmacol Ther 2018;181:183-96. [PMID: 28830838 DOI: 10.1016/j.pharmthera.2017.08.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Rong X, Liu X, Zheng D, Rong X, Chen F, Zhao P, Liu F, Ruan J. FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma. Cancer Cell Int 2020;20:196. [PMID: 32508532 DOI: 10.1186/s12935-020-01265-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kume T, Shackour T. Meta-analysis of the likelihood of FOXC1 expression in early- and late-stage tumors. Oncotarget 2018;9:36625-30. [PMID: 30564302 DOI: 10.18632/oncotarget.26358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Ma H, Lu L, Xia H, Xiang Q, Sun J, Xue J, Xiao T, Cheng C, Liu Q, Shi A. Circ0061052 regulation of FoxC1/Snail pathway via miR-515-5p is involved in the epithelial-mesenchymal transition of epithelial cells during cigarette smoke-induced airway remodeling. Sci Total Environ 2020;746:141181. [PMID: 32768781 DOI: 10.1016/j.scitotenv.2020.141181] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sun Y, Liu J, Chu L, Yang W, Liu H, Li C, Yang J. Long noncoding RNA SNHG12 facilitates the tumorigenesis of glioma through miR-101-3p/FOXP1 axis. Gene 2018;676:315-21. [PMID: 30098431 DOI: 10.1016/j.gene.2018.08.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
5 Wang Y, Qiu W, Liu N, Sun L, Liu Z, Wang S, Wang P, Liu S, Lv J. Forkhead box K1 regulates the malignant behavior of gastric cancer by inhibiting autophagy. Ann Transl Med 2020;8:107. [PMID: 32175400 DOI: 10.21037/atm.2019.12.123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yang Z, Jiang S, Cheng Y, Li T, Hu W, Ma Z, Chen F, Yang Y. FOXC1 in cancer development and therapy: Deciphering its emerging and divergent roles. Ther Adv Med Oncol. 2017;9:797-816. [PMID: 29449899 DOI: 10.1177/1758834017742576] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
7 Xia S, Qu J, Jia H, He W, Li J, Zhao L, Mao M, Zhao Y. Overexpression of Forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease. Life Sci 2019;216:75-84. [PMID: 30428305 DOI: 10.1016/j.lfs.2018.11.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yang Y, Jiang H, Li W, Chen L, Zhu W, Xian Y, Han Z, Yin L, Liu Y, Wang Y, Pan K, Zhang K. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer. Aging (Albany NY) 2020;12:24424-40. [PMID: 33291076 DOI: 10.18632/aging.202300] [Reference Citation Analysis]
9 Shang H, Shi L, Jiang X, Zhou P, Wei Y. Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients. Med Sci Monit 2021;27:e928763. [PMID: 33483461 DOI: 10.12659/MSM.928763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alemi F, Raei Sadigh A, Malakoti F, Elhaei Y, Ghaffari SH, Maleki M, Asemi Z, Yousefi B, Targhazeh N, Majidinia M. Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk. J Cell Physiol 2021. [PMID: 34515349 DOI: 10.1002/jcp.30573] [Reference Citation Analysis]
11 Bévant K, Desoteux M, Angenard G, Pineau R, Caruso S, Louis C, Papoutsoglou P, Sulpice L, Gilot D, Zucman-Rossi J, Coulouarn C. TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer. Hepatol Commun 2021. [PMID: 34825776 DOI: 10.1002/hep4.1866] [Reference Citation Analysis]
12 Cao S, Wang Z, Gao X, He W, Cai Y, Chen H, Xu R. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. J Exp Clin Cancer Res 2018;37:220. [PMID: 30189871 DOI: 10.1186/s13046-018-0894-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
13 Kong X, Zhai J, Yan C, Song Y, Wang J, Bai X, Brown JAL, Fang Y. Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies. Front Oncol 2019;9:234. [PMID: 31214487 DOI: 10.3389/fonc.2019.00234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Liu Y, Tu M, Wang L. Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy. IJGM 2022;Volume 15:2171-85. [DOI: 10.2147/ijgm.s354195] [Reference Citation Analysis]
15 Liang C, Zhao J, Ge H, Li G, Wu J. Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis. Onco Targets Ther 2018;11:3561-71. [PMID: 29950861 DOI: 10.2147/OTT.S155541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Gurnari C, Falconi G, De Bellis E, Voso MT, Fabiani E. The Role of Forkhead Box Proteins in Acute Myeloid Leukemia. Cancers (Basel) 2019;11:E865. [PMID: 31234353 DOI: 10.3390/cancers11060865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gouazé-Andersson V, Ghérardi MJ, Lemarié A, Gilhodes J, Lubrano V, Arnauduc F, Cohen-Jonathan Moyal E, Toulas C. FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker. Oncotarget 2018;9:31637-49. [PMID: 30167084 DOI: 10.18632/oncotarget.25827] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
18 Wang XH, Cui YX, Wang ZM, Liu J. Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun 2018;500:229-35. [PMID: 29634928 DOI: 10.1016/j.bbrc.2018.04.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
19 Song S, Zhang R, Cao W, Fang G, Yu Y, Wan Y, Wang C, Li Y, Wang Q. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J Cell Physiol 2019;234:9052-64. [PMID: 30378114 DOI: 10.1002/jcp.27583] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
20 Wang W, Shang Y, Wang C, Ni J, Wang A, Li G, Su L, Chen S. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression. Acta Pharmacol Sin. [DOI: 10.1038/s41401-022-00905-7] [Reference Citation Analysis]
21 Zhang N, Pati D. Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth. J Cancer Sci Ther 2018;10:517. [PMID: 29780443 DOI: 10.4172/1948-5956.1000517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
22 Lan C, Tan J, Tang L, Liu G, Huang L, Luo X, Zhou L, Zhu Y, Liu X, Fan N. Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy. Exp Eye Res 2021;210:108725. [PMID: 34375589 DOI: 10.1016/j.exer.2021.108725] [Reference Citation Analysis]
23 Subramani R, Camacho FA, Levin CI, Flores K, Clift A, Galvez A, Terres M, Rivera S, Kolli SN, Dodderer J, Miranda M, Rodriguez A, Pedroza DA, Chatterjee A, Lakshmanaswamy R. FOXC1 plays a crucial role in the growth of pancreatic cancer. Oncogenesis 2018;7:52. [PMID: 29976975 DOI: 10.1038/s41389-018-0061-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]